Insight Enterprises, Inc., together with its subsidiaries, provides information technology, hardware, software, and services in the United States, rest of North America, Europe, Middle East, Africa, and the Asia-Pacific.
FAIL · Does not pass the screen
175.62 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 04:07 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price175.62 USD at the 4 Nov 2026 close
Our value readFair vs our fair value, as of 4 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.75, read 2026-11-03
Ethical does not pass the values gate
Price175.62 USD
Fair value180.00
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-07-02Read Markup111.05+58.1% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Insight Enterprises, Inc. holds its Markup at $175.62. Consolidating, no directional conviction, held for 99 days.
As held on the ledger · 2026-11-04
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 99 days
Price at the screen
$175.62
Valuation
25.75 trailing · 13.25 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.06
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
17.46%
Below 33%
Interest-bearing debt is just 17.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
64.65%
Below 49%
Money owed to the company is 64.7% of assets, above the 49% limit.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Insight Enterprises,'s business is fine, but its receivables are about 65% of its assets, well over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when NSIT's ethical verdict changes
Today NSIT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades at roughly a 2% discount to our $180.00 fair value, 14.70% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 2.4% discount to the base estimate.
Where our models see it going: fair-value estimate $180.00, with a range of $180.00 to $351.24, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Tech distributor stuck with slim margins and flat sales
Picture a company that moves servers and cloud licences the way a wholesaler shifts boxes of fruit. Insight Enterprises sits in that middle ground, handling hardware, software and multicloud work across several continents. Revenue is barely growing at 1 percent, profit margins sit at just 2 percent and return on equity reaches only 11 percent, so the business does not generate standout returns even when times are steady.
The forward multiple of 9.3 times earnings looks cheap next to our fair value of 135 dollars against the current price of 115 dollars. Yet the low growth, thin margins and unknown competitive edge point to a classic cyclical value trap where earnings could already be near peak and the multiple offers no real margin of safety. Analyst targets cluster around 110 dollars, reinforcing that the market sees limited upside.
Risk sits in exposure to corporate IT budgets that can swing sharply with economic cycles and currency moves, plus an unclear moat in a crowded distribution space. The ethical screen passes cleanly, yet the numbers still fail to show a compelling case. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
NSIT trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup$175.62+4.9%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Markup$167.35-3.1%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markup$172.74+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markup$172.74+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markup$172.74-2.3%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markup$176.77+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markup$176.77+0.0%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markup$176.77+3.3%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 60% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$171.19+3.1%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 48% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103.
2026-10-18Markup$166.01+5.9%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it buy, with a mean price target of $103.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
